Immunocore (United Kingdom)

Recent papers from Immunocore (United Kingdom)

1. Human CD1c-autoreactive T-cells recognise Mycobacterium tuberculosis-infected antigen-presenting cells and display cytotoxic effector programmeseLife · 2026
2. The RISER Formula: A Mathematical Framework for Quantifying Relative Interchangeable Space Expansion Rate2026
3. ImmTACs overcome cytotoxic T cell suppressionImmunotherapy Advances · 2026
4. Phase 1/2 study of IMC-C103C, a T cell receptor bispecific (MAGE-A4×CD3) ImmTAC targeting MAGE-A4-expressing malignanciesENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2026
5. P46 CD1a-targeted PD-1 agonists for localized immunosuppression in atopic dermatitisBritish Journal of Dermatology · 2026
6. Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025Pigment Cell & Melanoma Research · 2026
7. Casting a wider net: Immunosurveillance by nonclassical MHC molecules2019
8. Effect of IL7 on ImmTAC-mediated killing by T cells in vitro and T-cell fitness in patients.Journal of Clinical Oncology · 2026
9. Phase 1 evaluation of the PRAME-targeted ImmTAC brenetafusp in advanced melanoma (Mel).Journal of Clinical Oncology · 2026
10. Intranasal boosting enhances genital tract T cell immunity following ChAdOx1/MVA hrHPV therapeutic vaccinationnpj Vaccines · 2026
11. Abstract CT029: Five-year survival with tebentafusp in previously untreated metastatic uveal melanoma in a phase 3 trialCancer Research · 2026
12. Beta cell–targeted PD-1 agonist inhibits cell-mediated autoimmunity in pancreas tissue slicesScience Advances · 2026
13. Human CD1c-autoreactive T cells recognise Mycobacterium tuberculosis–infected antigen-presenting cells and display cytotoxic effector programmeseLife · 2026
14. Safety and biologic activity of a bispecific T cell receptor targeting HIV Gag in males living with HIV: a first-in-human trialNature Communications · 2026
15. Ligand-responsive groove remodelling in human and macaque CD1d reveals a conserved MHC-like gating mechanism2025
16. Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slices2025
17. TIM3 is a context-dependent coregulator of cytotoxic T cell functionScience Signaling · 2025
18. T-cell signaling relies on partial CD45-exclusion at sub-micron sized cellular contacts2025
19. Cell-targeted PD-1 agonists are potent NK-cell inhibitorsFrontiers in Immunology · 2025
20. A CD1c lipid agnostic T cell receptor bispecific engager redirects T cells against CD1c+ cellsFrontiers in Immunology · 2025